Breast Imaging Market
Breast Imaging Market Size, Share & Trends Analysis Report by Type of Imaging Technique (Mammography, Breast Ultrasound, Breast MRI, Image-guided breast biopsy), by End Users (Hospitals, Diagnostic Centers, Others), by Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)
|Forecast Years for Breast Imaging Market:||2022 - 2028|
|Historical Years for Breast Imaging Market:||2016 - 2021|
|Revenue 2021 for Breast Imaging Market:||3,629.40 USD Million|
|Revenue 2028 for Breast Imaging:||5,632.59 USD Million|
|Revenue CAGR (2022 - 2028) for Breast Imaging Market :||7.60%|
|Fastest Growing Region (2022 - 2028) for Breast Imaging Market:||Asia Pacific|
|Largest Region (2021) for Breast Imaging Market:||North America|
Global breast imaging market is valued at 3,629.40 USD Million in 2021 and is projected to reach a value of 5,632.59 USD Million by 2028 at a CAGR of 7.60% over the forecast period. Breast imaging is a subspecialty of diagnostic radiology that uses ionizing or non-ionizing radiation to detect tumors in the breast. This technique allows clinicians to make an early diagnosis before the actual symptoms are present. The development of hybrid imaging systems and the extensive research in the development of hybrid imaging systems provide the market with significant growth opportunities over the forecast period. The global incidence of breast cancer is rising, and the burden of women with a backlog of cancer screening appointments due to COVID-19, has underlined the importance of women’s health and early detection of cancer. Breast cancer is expected to become the most diagnosed cancer, surpassing lung cancer as the most prevalent. The heightened expectations for government screening programs are a result of the world's steady increase in breast cancer incidence. To reduce breast cancer mortality, screening programs alone are not enough, accuracy in breast cancer detection must be improved, while false positives and missed lesions must also be reduced. These factors are expected to be at the forefront of breast imaging for both screening and diagnosis. The breast imaging market is fueled by stronger awareness of the benefits of breast cancer screening programs, as well as the need to improve breast cancer detection accuracy. This, along with a patient-centric approach to screening and technological advances to improve patient comfort, are among the methods being employed to improve participation in screening programs, which in turn has boosted the adoption of mammography X-ray equipment.
The global breast imaging market is classified into type of imaging technique, end user, and region. On the basis of type of imaging technique, the target market is bifurcated as mammography, breast ultrasound, breast MRI, image-guided breast biopsy and other imaging techniques. Based on end user, the target market is segmented as hospitals, diagnostic centers, and others.
Below tree is interactive. You can click the nodes to get more information.
The mammography segment holds the largest market share during the forecast period
The mammography segment in ionizing technology of the global breast imaging market is growing because of many initiatives taken for the early detection of breast cancer. The United States Preventive Services Task Force, for example, has developed guidelines for mammography screening. Moreover, the growing geriatric population and the rising incidence of breast cancer globally will push mammography demand up. According to the American Cancer Society, in the United States, there were 8,130 Ductal carcinomas in situ ( DCIS ) and 37,150 new cases of invasive breast cancer among women aged 40 to 49 years in 2019. The 3D breast tomosynthesis segment is expected to grow at the fastest CAGR during the forecast period because of the rising incidence of breast cancer. This growth is attributable mainly to this technology’s sharp image outputs and reduced recall rates. 3D breast tomosynthesis also overcomes the limitations of standard mammography by allowing detection of all types of lesions.
Hospitals segment accounts for the largest market share during the forecast period
Hospitals hold the largest share of the overall breast imaging market in 2020, with a combination of increased spending on healthcare infrastructure, higher purchasing power, more equipped operating and diagnostic rooms, as well as better health coverage for hospital-based healthcare services.
Asia Pacific region dominated the Breast Imaging Market during the forecast period
North America holds largest share of the global breast imaging market in 2017. This is mainly due to rise in prevalence of breast cancer, rising healthcare expenditure, and use of breast imaging as screening. However, Asia Pacific is expected to be the fastest growing region and the segment would grow at a high CAGR during the forecast period. This can be credited to increase in incidence of cancer in this region, as well as increased prevalence of early detection and diagnosis of breast cancer. The increase in the number of healthcare providers and radiology centers is expected to provide impetus to the target market. Additionally, increase in demand for advanced imaging technology including PET-CT and MRI are also driving the global breast imaging market growth in the region. Another key factor fueling the market's growth is frequency of breast screening programs to raise awareness about the importance of early diagnosis in the region.
Some of the major key players in the breast imaging market are Hologic, Inc. (US), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Canon Inc. (Japan), Siemens Healthineers (Germany), Aurora Healthcare US Corp. (US), Fujifilm Holdings Corporation (Japan), Allengers (India), Dilon Technologies, Inc. (US), Delphinus Medical Technologies, Inc. (US), Planmed Oy (Finland), Micrima Limited (UK), SuperSonic Imagine (France), CMR Naviscan Corporation (US), and Carestream Health (US).
Breast Imaging Market is segmented as follows:
Regions & Countries Covered
Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST
analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market
attractiveness analysis by segments and North America, company market share analysis, and COVID-19
Breast Imaging Market is tabulated as follows:
Frequently Asked Questions
the global demand for Breast Imaging
in terms of revenue?
The global Breast Imaging valued at 3,629.40 USD Million in 2020 and is expected to reach 5,632.59 USD Million in 2028 growing at a CAGR of 7.60%
are the prominent players
in the market?
The prominent players in the market are Hologic, Inc. (US), GE Healthcare (US), Siemens Healthineers (Germany), Koninklijke Philips N.V. (Netherlands), Fujifilm Holdings Corporation (Japan), Canon Inc. (Japan), Aurora Healthcare US Corp. (US), Allengers (India), Dilon Technologies, Inc. (US), Planmed Oy (Finland), Delphinus Medical Technologies, Inc. (US), Micrima Limited (UK), CMR Naviscan Corporation (US), SuperSonic Imagine (France), and Carestream Health (US).
At what CAGR is the market projected to grow within the forecast period?
The market is project to grow at a CAGR of 7.60% between 2021 and 2028.
the driving factors
fueling the growth of the market.
The driving factors of the Breast Imaging include
- increasing incidence of breast cancer
region accounted for the
largest share in the market?
North America was the leading regional segment of the Breast Imaging in 2020.